Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGYG.L Regulatory News (GYG)

  • There is currently no data for GYG

Pre-Close Period Statement

14 Jul 2006 07:00

Gyrus Group PLC14 July 2006 14th July 2006 Gyrus Group PLC Pre-Close Period Statement Reading, UK - Gyrus Group (GYG.L) a leading supplier of medical devices whichreduce trauma and complications in surgery, today provides a pre-close periodupdate ahead of its interim results announcement on 12th September 2006. The Group's reported revenues for the six months to 30th June 2006 areanticipated to be approximately £107 million representing growth of over 125% onthe previous year (2005: £47.3 million). Proforma organic revenue growth (whichassumes a full period comparative for the ACMI business which was acquired on21st July 2005) is expected to be marginally over 10%. The legacy Gyrusbusinesses grew revenue by approximately 17% over the first half of 2005 (12% ona constant exchange rate basis). Good performances from the Group's proprietaryDivisions in the US and the Partnered Technologies Division were partly offsetby a weaker performance in international markets, where the integration ofinternational distributors during the period caused a shortfall in revenues. The Surgical Division's new PlasmaCision-derived products (G400 generator,Plasma Trissector, Plasma J Hook) were introduced to the general surgery marketin late March and the technology has been well received during this initialevaluation phase. At the end of the period there were approximately 100 G400generators either placed or sold into the surgical market and the divisionachieved revenue in excess of $1 million from the PlasmaCision portfolio. The Urology & Gynaecology Division had a slower first half when compared to astrong 2005 result pre-acquisition, however the adoption of PK SuperPulse intothe legacy ACMI urology accounts has started well with sales in excess of theCompany's forecasts. New product introductions, including the early evaluationof the new digital ureteroscope, show significant potential for the second halfof 2006. The integration programme has continued on track and savings from this, togetherwith revenue orientated towards more profitable US domestic disposables sales,is expected to result in a significant enhancement to operating profitability. Subject to any unforeseen adjustments it is anticipated that underlying "adjusted" earnings per share (excluding amortisation of acquired intangibleassets, integration costs and deferred tax adjustments) for the six months to30th June 2006 will be in line with consensus expectations, which currentlystand at 7.3 pence per share (H1 2005: 5.1 pence). Brian Steer, Executive Chairman of Gyrus said: "The first half of 2006 has been a successful period of change; we have madesignificant inroads into the integration programme and have started tore-orientate the legacy ACMI business towards our disposable devices businessmodel. At the same time we have successfully introduced our important newPlasmaCision technology. In addition, we look forward to a number of potentiallysignificant new product launches in the second half of 2006." Enquiries: Gyrus Group PLCBrian Steer Executive Chairman 01189 219 750Simon Shaw Chief Financial Officer 01189 219 750 Financial DynamicsBen Atwell 0207 269 7242 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Sep 20217:00 amRNS2021 Interim Results
29th Sep 20219:54 amRNSForm 8.3 - [GYG Plc]
29th Sep 20219:40 amRNSForm 8.5 (EPT/RI)
28th Sep 202110:50 amRNSForm 8.5 (EPT/RI)
23rd Sep 20219:48 amRNSForm 8.5 (EPT/RI)
22nd Sep 202110:47 amRNSForm 8.3 - GYG plc / Harwood Capital LLP
22nd Sep 202110:34 amRNSForm 8.5 (EPT/RI)
21st Sep 202110:03 amRNSForm 8.5 (EPT/RI)
21st Sep 20219:48 amRNSForm 8.3 - [GYG Plc]
20th Sep 20212:02 pmRNSForm 8.3 - GYG plc / Harwood Capital LLP
20th Sep 202111:32 amRNSForm 8.5 (EPT/RI)
20th Sep 202111:02 amRNSForm 8.3 - [GYG PLC]
17th Sep 20211:18 pmRNSExtension of deadline under Rule 2.6c of the Code
17th Sep 202110:17 amRNSForm 8.3 - GYG plc / Harwood Capital LLP
17th Sep 20219:23 amRNSForm 8.5 (EPT/RI)
16th Sep 20219:59 amRNSForm 8.5 (EPT/RI)
15th Sep 202111:59 amRNSForm 8.3 - GYG plc / Harwood Capital LLP
15th Sep 202111:23 amRNSForm 8.5 (EPT/RI)
15th Sep 20219:51 amRNSForm 8.3 - [GYG Plc]
3rd Sep 20214:02 pmRNSForm 8.3 - GYG plc (Amendment)
3rd Sep 20212:39 pmRNSForm 8.3 - GYG plc
3rd Sep 202110:47 amRNSForm 8.5 (EPT/RI)
2nd Sep 20211:08 pmBUSForm 8.3 - GYG
26th Aug 202110:24 amRNSForm 8.5 (EPT/RI)
25th Aug 202112:05 pmRNSForm 8.3 - [GYG PLC]
24th Aug 20219:18 amRNSForm 8.5 (EPT/RI)
20th Aug 20213:43 pmRNSExtension of deadline under Rule 2.6c of the Code
20th Aug 20219:25 amRNSForm 8.5 (EPT/RI)
17th Aug 202111:03 amRNSForm 8.5 (EPT/RI)
13th Aug 202111:56 amRNSForm 8.3 - GYG PLC ORD
10th Aug 20219:24 amRNSForm 8.5 (EPT/RI)
9th Aug 202111:29 amRNSForm 8.5 (EPT/RI)
5th Aug 202112:52 pmRNSForm 8.3 - GYG plc / Harwood Capital LLP
5th Aug 202110:25 amRNSForm 8.5 (EPT/RI)
4th Aug 202111:30 amRNSForm 8.5 (EPT/RI)
3rd Aug 202112:45 pmRNSForm 8.3 - GYG plc / Harwood Capital LLP
3rd Aug 202112:42 pmRNSForm 8.3 - GYG plc / Harwood Capital LLP
29th Jul 202111:56 amRNSForm 8.3 - GYG plc / Harwood Capital LLP
29th Jul 202110:11 amRNSForm 8.5 (EPT/RI)
28th Jul 202111:47 amRNSForm 8.5 (EPT/RI)
28th Jul 20217:00 amRNSFinancial and Trading Update
27th Jul 202110:30 amRNSForm 8.5 (EPT/RI)
23rd Jul 20211:00 pmRNSExtension of deadline under Rule 2.6c of the Code
8th Jul 20219:57 amRNSForm 8.5 (EPT/RI)
6th Jul 202112:15 pmRNSForm 8.3 - [GYG PLC]
2nd Jul 20219:22 amRNSForm 8.5 (EPT/RI)
2nd Jul 20217:00 amRNSExtension of deadline under Rule 2.6c of the Code
1st Jul 202110:57 amRNSForm 8.3 - GYG Plc
29th Jun 202112:09 pmRNSForm 8.3 - [GYG Plc]
29th Jun 202110:00 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.